Search

Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents.

… Thursday, November 8, 2018 Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents, according to data we presented at the American Society of Clinical Oncology’s annual meeting

In this Q&A we discuss MSK’s pioneering work in rectal MRI, how it differs from endorectal ultrasound (ERUS), its role in groundbreaking clinical trials for patients with rectal cancer, why expertise matters, and new frontiers for future improvements to rectal MRI.

… Thursday, June 26, 2025 A Q&A with Dr. Marc J. Gollub, MSK’s Director of Gastrointestinal Radiology Memorial Sloan Kettering Cancer Center (MSK) has one of the busiest rectal cancer practices and likely performs the most rectal magnetic resonance imaging (MRI) exams in the United States. In this Q&A

A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

… Thursday, April 3, 2008 A study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells. Metastasis is the cause of approximately 90 percent of all cancer-related deaths.

People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.

… Tuesday, July 13, 2021 When it comes to body fat, what type you have and where it’s located is just as important as how much you have. Some people who are technically overweight are perfectly healthy because of where their fat is stored — subcutaneously (under the skin) rather than viscerally (around

A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities.

… Saturday, January 1, 2011 Summary A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities. A decade ago, the Sloan Kettering Institute embarked on the largest effort to broaden and streamline its research activities in its 65-year-long history

Our recent research confirms that total gastrectomy should be considered for all patients with the CDH1 gene mutation that carries a high risk for developing hereditary diffuse gastric cancer.

… Friday, January 5, 2018 Our recent research confirms that total gastrectomy should be considered for all patients with the CDH1 gene mutation that carries a high risk for developing hereditary diffuse gastric cancer. In our study, published in the Annals of Surgery in December 2017, none of the 41 patients

For people who are unable to find a matched bone marrow or stem cell donor, a cord blood transplant may offer the best chance for being cured of blood cancer.

… Thursday, August 30, 2018 Summary For people who don’t have a matched bone marrow or stem cell donor, a cord blood transplant may offer the best chance for being cured of blood cancer. Allogeneic stem cell or bone marrow transplants can be lifesavers for people with a blood cancer such as leukemia or

An effort to develop a radiation test after 9/11 inspires a trip through medical history.

… Wednesday, September 7, 2016 Summary Efforts to understand the effect of radiation on healthy tissues and cancer in the body have a long history. An MSK doctor was inspired to explore that history after helping to develop a test to detect radiation exposure. Highlights Simple blood tests to assess radiation

Learn what bladder cancer symptoms can mean in men and women.

… Wednesday, October 26, 2022 Bladder cancer does not affect men and women in the same ways. Knowing the warning signs of bladder cancer can lead to early diagnosis, which greatly improves outcomes. Bladder cancer is the sixth most common cancer in the United States. But there are differences between men

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

… Wednesday, March 13, 2013 Summary Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells. Scientists from Memorial Sloan Kettering have discovered